BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29572508)

  • 1. Structural basis of DUX4/IGH-driven transactivation.
    Dong X; Zhang W; Wu H; Huang J; Zhang M; Wang P; Zhang H; Chen Z; Chen SJ; Meng G
    Leukemia; 2018 Jun; 32(6):1466-1476. PubMed ID: 29572508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA crosslinking and recombination-activating genes 1/2 (RAG1/2) are required for oncogenic splicing in acute lymphoblastic leukemia.
    Zhang H; Cheng N; Li Z; Bai L; Fang C; Li Y; Zhang W; Dong X; Jiang M; Liang Y; Zhang S; Mi J; Zhu J; Zhang Y; Chen SJ; Zhao Y; Weng XQ; Hu W; Chen Z; Huang J; Meng G
    Cancer Commun (Lond); 2021 Nov; 41(11):1116-1136. PubMed ID: 34699692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor 12-mediated self-feedback regulatory mechanism is required in DUX4 fusion leukaemia.
    Li Z; Jiang M; Wang J; Zhuo Z; Zhang S; Tan Y; Hu W; Zhang H; Meng G
    Clin Transl Med; 2023 Dec; 13(12):e1514. PubMed ID: 38115701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-read sequencing unveils IGH-DUX4 translocation into the silenced IGH allele in B-cell acute lymphoblastic leukemia.
    Tian L; Shao Y; Nance S; Dang J; Xu B; Ma X; Li Y; Ju B; Dong L; Newman S; Zhou X; Schreiner P; Tseng E; Hon T; Ashby M; Li C; Easton J; Gruber TA; Zhang J
    Nat Commun; 2019 Jun; 10(1):2789. PubMed ID: 31243274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comment on structural basis of DUX4/IGH-driven transactivation.
    Aihara H; Shi K; Lee JK; Bosnakovski D; Kyba M
    Leukemia; 2018 Sep; 32(9):2090-2092. PubMed ID: 30054554
    [No Abstract]   [Full Text] [Related]  

  • 6. Crystal Structure of the Double Homeodomain of DUX4 in Complex with DNA.
    Lee JK; Bosnakovski D; Toso EA; Dinh T; Banerjee S; Bohl TE; Shi K; Orellana K; Kyba M; Aihara H
    Cell Rep; 2018 Dec; 25(11):2955-2962.e3. PubMed ID: 30540931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for multiple gene regulation by human DUX4.
    Li Y; Wu B; Liu H; Gao Y; Yang C; Chen X; Zhang J; Chen Y; Gu Y; Li J; Ma J; Gan J
    Biochem Biophys Res Commun; 2018 Nov; 505(4):1161-1167. PubMed ID: 30322619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.
    Yasuda T; Tsuzuki S; Kawazu M; Hayakawa F; Kojima S; Ueno T; Imoto N; Kohsaka S; Kunita A; Doi K; Sakura T; Yujiri T; Kondo E; Fujimaki K; Ueda Y; Aoyama Y; Ohtake S; Takita J; Sai E; Taniwaki M; Kurokawa M; Morishita S; Fukayama M; Kiyoi H; Miyazaki Y; Naoe T; Mano H
    Nat Genet; 2016 May; 48(5):569-74. PubMed ID: 27019113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.
    Zhang J; McCastlain K; Yoshihara H; Xu B; Chang Y; Churchman ML; Wu G; Li Y; Wei L; Iacobucci I; Liu Y; Qu C; Wen J; Edmonson M; Payne-Turner D; Kaufmann KB; Takayanagi SI; Wienholds E; Waanders E; Ntziachristos P; Bakogianni S; Wang J; Aifantis I; Roberts KG; Ma J; Song G; Easton J; Mulder HL; Chen X; Newman S; Ma X; Rusch M; Gupta P; Boggs K; Vadodaria B; Dalton J; Liu Y; Valentine ML; Ding L; Lu C; Fulton RS; Fulton L; Tabib Y; Ochoa K; Devidas M; Pei D; Cheng C; Yang J; Evans WE; Relling MV; Pui CH; Jeha S; Harvey RC; Chen IL; Willman CL; Marcucci G; Bloomfield CD; Kohlschmidt J; Mrózek K; Paietta E; Tallman MS; Stock W; Foster MC; Racevskis J; Rowe JM; Luger S; Kornblau SM; Shurtleff SA; Raimondi SC; Mardis ER; Wilson RK; Dick JE; Hunger SP; Loh ML; Downing JR; Mullighan CG;
    Nat Genet; 2016 Dec; 48(12):1481-1489. PubMed ID: 27776115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DUX4
    Dong X; Zhang H; Cheng N; Li K; Meng G
    Leukemia; 2019 Feb; 33(2):550-553. PubMed ID: 30315230
    [No Abstract]   [Full Text] [Related]  

  • 11. Transcriptional activities of DUX4 fusions in B-cell acute lymphoblastic leukemia.
    Tanaka Y; Kawazu M; Yasuda T; Tamura M; Hayakawa F; Kojima S; Ueno T; Kiyoi H; Naoe T; Mano H
    Haematologica; 2018 Nov; 103(11):e522-e526. PubMed ID: 29773604
    [No Abstract]   [Full Text] [Related]  

  • 12. The highest affinity DNA element bound by Pbx complexes in t(1;19) leukemic cells fails to mediate cooperative DNA-binding or cooperative transactivation by E2a-Pbx1 and class I Hox proteins - evidence for selective targetting of E2a-Pbx1 to a subset of Pbx-recognition elements.
    Knoepfler PS; Kamps MP
    Oncogene; 1997 May; 14(21):2521-31. PubMed ID: 9191052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Submicroscopic deletions of immunoglobulin heavy chain gene (IGH) in precursor B lymphoblastic leukemia with IGH rearrangements.
    Huh J; Mun YC; Yoo ES; Seong CM; Chung WS
    Ann Lab Med; 2015 Jan; 35(1):128-31. PubMed ID: 25553293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-125b-1 and BLID upregulation resulting from a novel IGH translocation in childhood B-Cell precursor acute lymphoblastic leukemia.
    Tassano E; Acquila M; Tavella E; Micalizzi C; Panarello C; Morerio C
    Genes Chromosomes Cancer; 2010 Aug; 49(8):682-7. PubMed ID: 20544842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombination activating gene-1 (RAG-1) expression in all differentiation stages of B-lineage precursor acute lymphoblastic leukemia.
    Umiel T; Pattengale P; Weinberg K
    Leukemia; 1993 Mar; 7(3):435-40. PubMed ID: 8445948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotypic and cytogenetic findings of B-lymphoblastic leukemia/lymphoma associated with combined IGH/BCL2 and MYC rearrangement.
    Kelemen K; Holden J; Johnson LJ; Davion S; Robetorye RS
    Cytometry B Clin Cytom; 2017 Jul; 92(4):310-314. PubMed ID: 26517296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DUX4-r exerts a neomorphic activity that depends on GTF2I in acute lymphoblastic leukemia.
    Campolungo D; Salomé M; Biferali B; Tascini AS; Gabellini D
    Sci Adv; 2023 Sep; 9(37):eadi3771. PubMed ID: 37713484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related patterns of immunoglobulin and T-cell receptor gene rearrangements in precursor-B-ALL: implications for detection of minimal residual disease.
    van der Velden VH; Szczepanski T; Wijkhuijs JM; Hart PG; Hoogeveen PG; Hop WC; van Wering ER; van Dongen JJ
    Leukemia; 2003 Sep; 17(9):1834-44. PubMed ID: 12970784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia.
    Steeghs EMP; Bakker M; Hoogkamer AQ; Boer JM; Hartman QJ; Stalpers F; Escherich G; de Haas V; de Groot-Kruseman HA; Pieters R; den Boer ML
    Sci Rep; 2018 Jan; 8(1):693. PubMed ID: 29330417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic Leukemia.
    Shin S; Hwang IS; Kim J; Lee KA; Lee ST; Choi JR
    Ann Lab Med; 2017 Jul; 37(4):331-335. PubMed ID: 28445014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.